COSCIENS Biopharma Inc. Operating Expense
COSCIENS Biopharma Inc. (CSCIF) reported Operating Expense of $13.33 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:OperatingExpense · last filed 2026-03-25
- COSCIENS Biopharma Inc. operating expense for the quarter ending 2025-12-31 was $3.00M, a 64.56% decline year-over-year.
- COSCIENS Biopharma Inc. operating expense for the quarter ending 2025-09-30 was $2.94M, a 59.39% decline year-over-year.
- COSCIENS Biopharma Inc. operating expense for the quarter ending 2025-06-30 was $3.33M, a 27.26% decline year-over-year.
- COSCIENS Biopharma Inc. operating expense for the quarter ending 2025-03-31 was $4.06M, a 33.60% decline year-over-year.
| Period end | Operating Expense 3 month | Operating Expense 3 month as first filed | Operating Expense 6 month | Operating Expense 6 month as first filed | Operating Expense 9 month | Operating Expense 9 month as first filed | Operating Expense 12 month | Operating Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $3.00M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | $5.94M derived: sum of 2 quarters · filed 2026-03-25 | $9.27M derived: sum of 3 quarters · filed 2026-03-25 | $13.33M 20-F · filed 2026-03-25 | ||||
| 2025-09-30 | $2.94M 6-K · filed 2025-11-12 | $6.27M derived: sum of 2 quarters · filed 2025-11-12 | $10.33M 6-K · filed 2025-11-12 | $18.79M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2025-06-30 | $3.33M 6-K · filed 2025-08-14 | $7.39M 6-K · filed 2025-08-14 | $15.84M derived: sum of 3 quarters · filed 2026-03-25 | $23.09M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2025-03-31 | $4.06M derived: 20-F 12 month − 3 quarters · filed 2026-03-25 | $12.52M derived: sum of 2 quarters · filed 2026-03-25 | $19.77M derived: sum of 3 quarters · filed 2026-03-25 | $24.34M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2024-12-31 | $8.46M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | $15.71M derived: sum of 2 quarters · filed 2026-03-25 | $20.28M derived: sum of 3 quarters · filed 2026-03-25 | $23.01M 20-F · filed 2026-03-25 | ||||
| 2024-09-30 | $7.25M 6-K · filed 2025-11-12 | $11.82M derived: sum of 2 quarters · filed 2025-11-12 | $14.55M 6-K · filed 2025-11-12 | $9.52M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2024-06-30 | $4.57M 6-K · filed 2025-08-14 | $7.30M 6-K · filed 2025-08-14 | $2.27M derived: sum of 3 quarters · filed 2026-03-25 | $6.82M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2024-03-31 | $6.11M 6-K · filed 2024-05-16 | -$2.31M derived: sum of 2 quarters · filed 2026-03-25 | $2.25M derived: sum of 3 quarters · filed 2026-03-25 | $7.35M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2023-12-31 | -$8.42M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | -$3.87M derived: sum of 2 quarters · filed 2026-03-25 | $1.23M derived: sum of 3 quarters · filed 2026-03-25 | $7.57M 20-F · filed 2026-03-25 | $22.51M 20-F · filed 2024-03-27 | |||
| 2023-09-30 | $4.55M 6-K · filed 2023-11-09 | $9.65M derived: sum of 2 quarters · filed 2023-11-09 | $15.99M 6-K · filed 2023-11-09 | $5.82M derived: sum of 4 quarters · filed 2025-04-09 | ||||
| 2023-06-30 | $5.10M 6-K · filed 2023-08-09 | $11.44M 6-K · filed 2023-08-09 | $1.27M derived: sum of 3 quarters · filed 2025-04-09 | $6.85M derived: sum of 4 quarters · filed 2025-04-09 | ||||
| 2023-03-31 | $6.33M 6-K · filed 2024-05-16 | -$3.83M derived: sum of 2 quarters · filed 2025-04-09 | $1.75M derived: sum of 3 quarters · filed 2025-04-09 | $6.24M derived: sum of 4 quarters · filed 2025-04-09 | ||||
| 2022-12-31 | -$10.17M derived: 20-F 12 month − 6-K 9 month · filed 2025-04-09 | -$4.59M derived: sum of 2 quarters · filed 2025-04-09 | -$94.00K derived: sum of 3 quarters · filed 2025-04-09 | $4.24M 20-F · filed 2025-04-09 | $29.24M 20-F · filed 2023-03-23 | |||
| 2022-09-30 | $5.58M 6-K · filed 2023-11-09 | $10.07M derived: sum of 2 quarters · filed 2023-11-09 | $14.40M 6-K · filed 2023-11-09 | $18.49M derived: sum of 4 quarters · filed 2024-07-17 | ||||
| 2022-06-30 | $4.49M 6-K · filed 2023-08-09 | $8.82M 6-K · filed 2023-08-09 | $12.91M derived: sum of 3 quarters · filed 2024-07-17 | $16.02M derived: sum of 4 quarters · filed 2024-07-17 | ||||
| 2022-03-31 | $4.33M 6-K · filed 2023-05-09 | $8.42M derived: sum of 2 quarters · filed 2024-07-17 | $11.52M derived: sum of 3 quarters · filed 2024-07-17 | $15.26M derived: sum of 4 quarters · filed 2024-07-17 | ||||
| 2021-12-31 | $4.09M derived: 20-F/A 12 month − 6-K 9 month · filed 2024-07-17 | $7.19M derived: sum of 2 quarters · filed 2024-07-17 | $10.93M derived: sum of 3 quarters · filed 2024-07-17 | $13.93M 20-F/A · filed 2024-07-17 | ||||
| 2021-09-30 | $3.10M 6-K · filed 2022-11-03 | $2.42M 6-K · filed 2021-11-04 | $6.85M derived: sum of 2 quarters · filed 2022-11-03 | $9.84M 6-K · filed 2022-11-03 | $7.04M 6-K · filed 2021-11-04 | $13.46M derived: sum of 4 quarters · filed 2024-02-15 | ||
| 2021-06-30 | $3.74M 6-K/A · filed 2022-08-04 | $2.71M 6-K · filed 2021-08-05 | $6.74M 6-K/A · filed 2022-08-04 | $4.62M 6-K · filed 2021-08-05 | $10.36M derived: sum of 3 quarters · filed 2024-02-15 | $12.22M derived: sum of 4 quarters · filed 2024-02-15 | ||
| 2021-03-31 | $3.00M 6-K · filed 2022-05-11 | $1.90M 6-K · filed 2021-05-05 | $6.61M derived: sum of 2 quarters · filed 2024-02-15 | $8.48M derived: sum of 3 quarters · filed 2024-02-15 | $9.99M derived: sum of 4 quarters · filed 2024-02-15 | |||
| 2020-12-31 | $3.62M derived: 20-F/A 12 month − 6-K 9 month · filed 2024-02-15 | $5.48M derived: sum of 2 quarters · filed 2024-02-15 | $6.99M derived: sum of 3 quarters · filed 2024-02-15 | $9.36M 20-F/A · filed 2024-02-15 | ||||
| 2020-09-30 | $1.87M 6-K · filed 2021-11-04 | $3.38M derived: sum of 2 quarters · filed 2021-11-04 | $5.74M 6-K · filed 2021-11-04 | $7.52M derived: sum of 4 quarters · filed 2022-03-29 | ||||
| 2020-06-30 | $1.51M 6-K · filed 2021-08-05 | $3.88M 6-K · filed 2021-08-05 | $5.66M derived: sum of 3 quarters · filed 2022-03-29 | $7.75M derived: sum of 4 quarters · filed 2022-03-29 | ||||
| 2020-03-31 | $2.37M 6-K · filed 2021-05-05 | $4.15M derived: sum of 2 quarters · filed 2022-03-29 | $6.24M derived: sum of 3 quarters · filed 2022-03-29 | $10.17M derived: sum of 4 quarters · filed 2022-03-29 | ||||
| 2019-12-31 | $1.78M derived: 20-F 12 month − 6-K 9 month · filed 2022-03-29 | $3.87M derived: sum of 2 quarters · filed 2022-03-29 | $7.80M derived: sum of 3 quarters · filed 2022-03-29 | $10.77M 20-F · filed 2022-03-29 | ||||
| 2019-09-30 | $2.09M 6-K · filed 2020-11-05 | $6.02M derived: sum of 2 quarters · filed 2020-11-05 | $8.99M 6-K · filed 2020-11-05 | $8.89M 6-K · filed 2019-11-07 | $14.12M derived: sum of 4 quarters · filed 2020-11-05 | |||
| 2019-06-30 | $3.93M 6-K · filed 2020-08-06 | $3.83M 6-K · filed 2019-08-13 | $6.90M 6-K · filed 2020-08-06 | $6.80M 6-K · filed 2019-08-13 | $12.03M derived: sum of 3 quarters · filed 2020-08-06 | $15.21M derived: sum of 4 quarters · filed 2020-08-06 | ||
| 2019-03-31 | $2.98M 6-K/A · filed 2020-05-11 | $8.10M derived: sum of 2 quarters · filed 2020-05-11 | $11.28M derived: sum of 3 quarters · filed 2020-05-11 | $14.75M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $5.12M derived: 20-F 12 month − 6-K 9 month · filed 2020-03-31 | $8.30M derived: sum of 2 quarters · filed 2020-03-31 | $11.78M derived: sum of 3 quarters · filed 2020-03-31 | $17.04M 20-F · filed 2020-03-31 | $14.94M 20-F · filed 2019-04-01 | |||
| 2018-09-30 | $3.18M 6-K · filed 2019-11-07 | $6.66M derived: sum of 2 quarters · filed 2019-11-07 | $11.91M 6-K · filed 2019-11-07 | |||||
| 2018-06-30 | $3.48M 6-K · filed 2019-08-13 | $8.73M 6-K · filed 2019-08-13 | ||||||
| 2017-12-31 | $24.00M 20-F · filed 2020-03-31 | |||||||
| 2016-12-31 | $30.39M 20-F · filed 2019-04-01 | |||||||
| 2015-12-31 | $35.43M 20-F · filed 2018-03-28 |